US
Franklin Genomic Advancements ETF
HELX · Equity
$33.92
+1.01%
Assets
n/a
Expense ratio
0.50%
Holdings
66
1Y return
+32.7%
Forward P/E
n/a
Top 10 holdings
+43.3%
Return and risk
| 1Y total return | +32.7% |
| 3Y total return | +13.9% |
| 5Y total return | -17.2% |
| 3Y CAGR | +4.4% |
| 5Y CAGR | -3.7% |
| Beta | 1.01 |
| RSI | 51.72 |
Fund structure
| Asset class | Equity |
| Assets | n/a |
| Holdings | 66 |
| Expense ratio | 0.50% |
| Dividend yield | +0.4% |
| Top 10 holdings | +43.3% |
| Volume | 1.2K |
All ETF indicators
| All Time High | 58.61 |
| All Time High Change | -42.12 |
| All Time High Date | 2021-09-10 |
| All Time Low | 18.41 |
| All Time Low Change | 84.25 |
| All Time Low Date | 2020-03-23 |
| Atr | 0.48 |
| Beta | 1.01 |
| Cagr1y | 32.72 |
| Cagr3y | 4.43 |
| Cagr5y | -3.71 |
| Ch1m | 3.72 |
| Ch1w | 0.41 |
| Ch1y | 32.18 |
| Ch3m | -2.79 |
| Ch3y | 13.43 |
| Ch5y | -17.74 |
| Ch6m | -4.13 |
| Ch YTD | -6.57 |
| Close | 33.58 |
| Div CAGR3 | 6.68 |
| Dividend Growth | 0 |
| Dividend Growth Years | 3 |
| Dividend Years | 1 |
| Dividend Yield | 0.42 |
| Dps | 0.14 |
| Ex Div Date | 2025-12-30 |
| High52 | 38.17 |
| High52ch | -11.13 |
| High52 Date | 2026-01-07 |
| Inception Date | 2020-02-25 |
| Isin | US35473P5200 |
| Last Dividend | 0.14 |
| Low52 | 24.94 |
| Low52ch | 36.01 |
| Low52 Date | 2025-05-23 |
| Ma150 | 34.91 |
| Ma150ch | -2.83 |
| Ma20 | 33.85 |
| Ma200 | 33.63 |
| Ma200ch | 0.88 |
| Ma20ch | 0.22 |
| Ma50 | 33.24 |
| Ma50ch | 2.04 |
| Payment Date | 2026-01-08 |
| Payout Ratio | 12.52 |
| Price Date | 2026-05-12 |
| Rsi | 51.72 |
| Rsi Monthly | 54.24 |
| Rsi Weekly | 50.55 |
| Sharpe Ratio | 1.26 |
| Sortino Ratio | 2.24 |
| Top10holdings | 43.3 |
| Tr1m | 3.72 |
| Tr1y | 32.7 |
| Tr3m | -2.79 |
| Tr3y | 13.88 |
| Tr5y | -17.21 |
| Tr6m | -3.75 |
| Tr YTD | -6.57 |